Tianyi Chi

985 total citations
29 papers, 582 citations indexed

About

Tianyi Chi is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Tianyi Chi has authored 29 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 12 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in Tianyi Chi's work include Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Liver Disease Diagnosis and Treatment (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers). Tianyi Chi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Liver Disease Diagnosis and Treatment (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers). Tianyi Chi collaborates with scholars based in China, United States and Hong Kong. Tianyi Chi's co-authors include Paul B.S. Lai, George G. Chen, Haitao Zhao, Shunda Du, Xinting Sang, Shouxian Zhong, Yilei Mao, Yiyao Xu, Xin Lu and Huayu Yang and has published in prestigious journals such as Gut, Medicine and The American Journal of Surgery.

In The Last Decade

Tianyi Chi

27 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tianyi Chi China 12 242 218 181 145 119 29 582
Masaharu Tada Japan 9 331 1.4× 235 1.1× 160 0.9× 214 1.5× 231 1.9× 18 681
Wenbing Sun China 14 240 1.0× 126 0.6× 226 1.2× 121 0.8× 69 0.6× 25 602
Maria Chiara Cantarini Italy 7 467 1.9× 392 1.8× 188 1.0× 121 0.8× 109 0.9× 8 745
Quentin Bayard France 9 185 0.8× 162 0.7× 302 1.7× 105 0.7× 70 0.6× 13 630
Yadi Liao China 16 204 0.8× 137 0.6× 250 1.4× 126 0.9× 88 0.7× 21 582
Wai Meng David Tai Singapore 12 265 1.1× 130 0.6× 220 1.2× 280 1.9× 73 0.6× 33 645
Zengqiang Qu China 9 167 0.7× 167 0.8× 261 1.4× 114 0.8× 64 0.5× 19 567
Yasuji Komorizono Japan 11 618 2.6× 596 2.7× 119 0.7× 73 0.5× 136 1.1× 19 930
Cheng-Chung Wu Taiwan 14 155 0.6× 140 0.6× 259 1.4× 146 1.0× 92 0.8× 18 641
Kazuho Imanaka Japan 14 354 1.5× 344 1.6× 134 0.7× 171 1.2× 242 2.0× 29 901

Countries citing papers authored by Tianyi Chi

Since Specialization
Citations

This map shows the geographic impact of Tianyi Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianyi Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianyi Chi more than expected).

Fields of papers citing papers by Tianyi Chi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianyi Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianyi Chi. The network helps show where Tianyi Chi may publish in the future.

Co-authorship network of co-authors of Tianyi Chi

This figure shows the co-authorship network connecting the top 25 collaborators of Tianyi Chi. A scholar is included among the top collaborators of Tianyi Chi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianyi Chi. Tianyi Chi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Du, Shunda, Lijian Pei, Bo Zhu, et al.. (2017). Role of a selective cyclooxygenase-2 inhibitor on pain and enhanced recovery after open hepatectomy: a randomized controlled trial. Translational Cancer Research. 6(4). 806–814. 3 indexed citations
3.
Du, Shunda, Lijian Pei, Bo Zhu, et al.. (2017). Role of a selective cyclooxygenase-2 inhibitor on pain and enhanced recovery after open hepatectomy: a randomized controlled trial. Translational Cancer Research. 6(4). 806–814. 6 indexed citations
4.
Zheng, Yongchang, Xin Wang, Feihu Xie, et al.. (2017). Research progress on DNA methylation in hepatocellular carcinoma. Translational Cancer Research. 6(5). 981–998.
5.
Du, Shunda, Gang Liu, Xinqi Cheng, et al.. (2016). Differential Diagnosis of Immunoglobulin G4-associated Cholangitis From Cholangiocarcinoma. Journal of Clinical Gastroenterology. 50(6). 501–505. 14 indexed citations
6.
Xu, Yiyao, Huayu Yang, Yilei Mao, et al.. (2016). Application of associating liver partition and portal vein ligation for staged hepatectomy(ALPPS) in cirrhotic patients with hepatocellular carcinoma. Zhonghua putong waike zazhi. 31(7). 534–537. 1 indexed citations
7.
Du, Shunda, Zi Wang, Xinting Sang, et al.. (2015). Surgical Resection Improves the Outcome of the Patients With Neuroendocrine Tumor Liver Metastases. Medicine. 94(2). e388–e388. 26 indexed citations
8.
Yang, Xiaobo, Ruoyu Miao, Huayu Yang, et al.. (2014). Retrospective and comparative study of inflammatory myofibroblastic tumor of the liver. Journal of Gastroenterology and Hepatology. 30(5). 885–890. 8 indexed citations
9.
10.
Xu, Yiyao, Xin Lu, Yilei Mao, et al.. (2013). Clinical diagnosis and treatment of alpha-fetoprotein-negative small hepatic lesions.. PubMed. 25(4). 382–8. 7 indexed citations
11.
Yang, Huayu, Yilei Mao, Xin Lu, et al.. (2011). The effects of urinary trypsin inhibitor on liver function and inflammatory factors in patients undergoing hepatectomy: a prospective, randomized, controlled clinical study. The American Journal of Surgery. 202(2). 151–157. 12 indexed citations
12.
Mao, Yilei, Huayu Yang, Haifeng C. Xu, et al.. (2010). Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma. Gut. 59(12). 1687–1693. 209 indexed citations
13.
14.
Lu, Xin, Haitao Zhao, Huayu Yang, et al.. (2009). A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy. Journal of Surgical Oncology. 100(6). 488–493. 47 indexed citations
15.
Chi, Tianyi, et al.. (2008). [Diagnosis and treatment of pancreatic metastasis from renal cell carcinoma].. PubMed. 30(10). 793–6. 1 indexed citations
16.
Zhou, Li, Jing‐An Rui, Shuguang Chen, et al.. (2007). Factors predictive for long‐term survival of male patients with hepatocellular carcinoma after curative resection. Journal of Surgical Oncology. 95(4). 298–303. 35 indexed citations
17.
Zhou, Li, et al.. (2006). Clinicopathological features, post-surgical survival and prognostic indicators of elderly patients with hepatocellular carcinoma. European Journal of Surgical Oncology. 32(7). 767–772. 33 indexed citations
18.
Lai, Paul B.S., Tianyi Chi, & George G. Chen. (2006). Different levels of p53 induced either apoptosis or cell cycle arrest in a doxycycline-regulated hepatocellular carcinoma cell line in vitro. APOPTOSIS. 12(2). 387–393. 60 indexed citations
19.
20.
Chi, Tianyi, George G. Chen, & Paul B.S. Lai. (2004). Eicosapentaenoic Acid Induces Fas-Mediated Apoptosis Through a p53-Dependent Pathway in Hepatoma Cells. The Cancer Journal. 10(3). 190–200. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masaharu Tada Breakdown of academic impact, for papers by Wenbing Sun Breakdown of academic impact, for papers by Maria Chiara Cantarini Breakdown of academic impact, for papers by Quentin Bayard Breakdown of academic impact, for papers by Yadi Liao Breakdown of academic impact, for papers by Wai Meng David Tai Breakdown of academic impact, for papers by Zengqiang Qu Breakdown of academic impact, for papers by Yasuji Komorizono Breakdown of academic impact, for papers by Cheng-Chung Wu Breakdown of academic impact, for papers by Kazuho Imanaka
Rankless by CCL
2026